Are Prag Bosimi Synthetics Ltd latest results good or bad?

1 hour ago
share
Share Via
Prag Bosimi Synthetics Ltd's latest results are poor, showing a net loss of ₹3.56 crores and negative net sales of ₹0.50 crores, indicating significant operational challenges and a lack of revenue generation. The company is in distress, with negative shareholder equity and a precarious financial position.
Prag Bosimi Synthetics Ltd's latest financial results for Q4 FY26 indicate significant operational challenges. The company reported a net loss of ₹3.56 crores, which reflects a substantial increase in losses compared to the previous quarter. Additionally, net sales were recorded at negative ₹0.50 crores, suggesting that returns or adjustments exceeded gross sales, marking a complete failure in revenue generation. This performance represents a continued trend of operational decline, with a year-on-year decrease of 49.49% from the previous year's negative sales figures.
The operating profit before depreciation, interest, and tax (PBDIT) also turned negative at ₹0.85 crores, contrasting with a positive figure in the prior quarter. This operational loss, compounded by interest costs of ₹1.71 crores and depreciation of ₹2.39 crores, contributed to the widening net loss. The company’s financial position is further strained by negative shareholder equity of ₹3.77 crores, indicating technical insolvency. In terms of liquidity, current assets slightly exceed current liabilities, providing minimal cushion against immediate financial pressures. The company’s debt-to-equity ratio stands at a negative 17.25, reflecting a precarious capital structure. Furthermore, the absence of institutional interest, with only 0.13% of holdings from mutual funds, underscores a lack of confidence in the company’s financial viability. Overall, Prag Bosimi Synthetics Ltd exhibits characteristics of a company in distress, with no clear recovery path visible. The company saw an adjustment in its evaluation, reflecting the ongoing operational and financial difficulties it faces.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News